• Personal Injury Attorneys
• Alerts
  • Aged Tires
  • Cingular AT&T Charge
  • Defective Chinese Drywall
  • Defective Crib Recall
  • Denture Cream Risk
  • Digitek Recall
  • Duragesic Patch Recall
  • ETHEX Morphine Sulfate
  • Food Poisoning
  • Frozen Pizza Recall
  • Hydroxycut Warning
  • Medtronic Recall
  • MRI Injection Risk
  • Peanut Butter Contamination
  • Fleet Phospho Soda Recall
  • Popcorn Lung
  • Proshares Lawsuit
  • Quinine Alert
  • Raytheon Contamination
  • Reglan Recall
  • Shoulder Pain Pump Alert
  • Toyota Recall
  • Trasylol Recall
  • Yamaha Rhino Recall
• Automobile Safety
• Automobile Tips
• Back Injuries
• Brain Injuries
• Burn Injuries
• Child Care & Safety
• Children with Disabilities
• Crime
• Cruise Ship Safety
• Debt Harassment
• Defective Products
• Dog Bites
• Elderly Care
• Employment
• Health & Living
• House & Home
• Hurricanes
• Life Support
• Medical Malpractice
• Motorcycle Accidents
• Occupational Safety
• Personal Injury
• Personal Privacy
• Spinal Cord Injuries
• Sports Injuries
• Trauma
• Water Safety
• White Collar Crime

First Name:

Last Name:

Telephone:

Email:

Zip Code:

Incident Details:

Yes, I would like to receive
the Morgan & Morgan newsletter.

ETHEX Morphine Sulfate Recall

The lawyers at Morgan & Morgan are reviewing cases against ETHEX CORPORATION, a manufacturer of the pain medication Morphine Sulfate which admits to manufacturing and distributing Morphine pills with double the prescribed strength. Consumers are at the risk of morphine overdose which could lead to side effects including breathing problems, erratic behavior, seizures, low blood pressure, nausea and vomiting and even death.

On June 10, 2008 the FDA issued a MedWatch Email Alert, "Morphine Sulfate 60 mg Extended Release Tablets - Recall of a Single Lot Due to a Report of a Tablet With Twice the Appropriate Thickness". A few days later, however, ETHEX expanded their morphine pill recall to include specific additional lots of morphine sulfate 60 mg extended release tablets, and specific lots of morphine sulfate 30 mg extended release tablets, as a precaution, due to the possible presence of oversized tablets. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The recalled lots were distributed by ETHEX Corporation under an "ETHEX" label between June 2006 and May 2008. The lot numbers involved in the recall are:

Morphine Sulfate ER 30mg Tablet/NDC # 58177-320-04: Lots 75090, 77846, 77847, 80048, 83320, 89661, 89665, 90252 through 90258, and 93284

Morphine Sulfate ER 60mg Tablet/NDC # 58177-330-04: Lots 91762 (previously reported), 75091, 75092, 77848 through 77851, 82517, 82518, 83333, 83817, 83862, 84111, 84112, 84315, 84900, 85326, 85335, 85807, 86270 through 86276, 87723, 87939, 88007, 89083, 89668, 89669, 89821, 90260 through 90272, and 91763 through 91765.

According to the ETHEX June 13 Press Release, there are indications the drug company is unsure how and when the oversized tablets were being produced and distributed.

The lawyers at Morgan & Morgan are committed to holding this drug company accountable for subjecting consumers to overdose of this dangerous drug.